"Me-too" products--friend or foe?

N Engl J Med. 2004 Jan 15;350(3):211-2. doi: 10.1056/NEJMp038215.
No abstract available

Publication types

  • Comment

MeSH terms

  • Coronary Disease / therapy
  • Cost Savings*
  • Cost-Benefit Analysis
  • Drug Costs*
  • Economic Competition*
  • Health Care Costs
  • Humans
  • Paclitaxel / administration & dosage
  • Paclitaxel / economics
  • Sirolimus / administration & dosage
  • Sirolimus / economics
  • Stents / economics*
  • United States

Substances

  • Paclitaxel
  • Sirolimus